MedTrace Logo

Ciprofloxacin Utilization and Adverse Events Occurrence in Community Pharmacy Setting

NCT05916105 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 151

Last updated 2023-06-23

No results posted yet for this study

Summary

Background: Ciprofloxacin is a fluoroquinolone that is commonly used to treat a variety of diseases. Ciprofloxacin resistance is rising, resulting in suboptimal patient care. The goal of this study was to evaluate ciprofloxacin use in the community in terms of acceptable prescription, dose, frequency, and duration of use.

Methods: A cross-sectional research was done in Egyptian community pharmacies by community pharmacists. Patients who were administered oral ciprofloxacin during the research period were included.

Conditions

  • Ciprofloxacin Adverse Reaction

Interventions

DRUG

Ciprofloxacin Tablets

Ciprofloxacin antibiotic

Sponsors & Collaborators

  • Damanhour University

    lead OTHER

Principal Investigators

  • Rehab H Werida, Ass. Prof. · Damanhour University

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-09-01
Primary Completion
2022-02-28
Completion
2022-03-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05916105 on ClinicalTrials.gov